Search
for
Sort by
Research 241–270 of 1000+
- Genetic basis of polycystic ovary syndrome
- Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Toward a Diagnostic Score in Cushing's Syndrome
- Male pattern baldness and the risk of prostate cancer
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study
- Actinic Keratosis: Risk Factors, Clinical, Diagnosis and Therapeutics Aspects. Part I
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Immunization and Bacterial Pathogens in the Oropharynx as Risk Factors for Alopecia Areata
- Is Prenatal Sex Hormone Balance a Risk Factor for the Development of Hidradenitis Suppurativa
- Bloch-Sulzberger Syndrome: A Rare X-Linked Dominant Genetic Disorder in a Newborn
- Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress